Document is current
Any future updates will be listed below
-
Authors
LeVee, Alexis
Santos, Bethania
Wong, Megan
Ruel, Nora
Schmolze, Daniel
Kang, Irene
Tsai, Karen
Mortimer, Joanne
McArthur, Heather
- License Information
-
More Information
Article History
Received: 20 August 2025
Accepted: 4 May 2026
First Online: 28 May 2026
Declarations
:
: Alexis LeVee: Consultant/advisory board role for: Incyclix, AstraZeneca.Heather McArthur: Consultant/advisory board role for: ALX, Amgen, AstraZeneca, BeiGene, Boston Scientific, Bristol-Myers Squibb, Calithera, Celgene, Daiichi-Sankyo, Delcath Systems Inc., Eli Lilly, Genentech/Roche, Gilead, Immunomedics, Merck, Moderna, Novartis, OBI Pharma, Peregrine, Pfizer/Seattle Genetics, Puma, Spectrum Pharmaceuticals, Stemline Therapeutics, Syndax Pharmaceuticals, and TapImmune. Research support: Bristol-Myers Squibb; MedImmune, LLC/AstraZeneca; BTG; and Merck.Joanne Mortimer: Consulting for GE Healthcare. Research support from AstraZeneca, Daiichi Sankyo, and Pfizer.Irene Kang: Consultant for Caris Life Sciences, Gilead, Daiichi-Sankyo, Pfizer, Menarini-Stemline. Research support from Merck.
